The amyloid β-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1177-1184

  Sberna, Gian ^a   Sáez Valero, Javier ^a   Beyreuther, Konrad ^b   Masters, Colin L ^a   Small, David H ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Amyloid protein; Cyclic AMP; Voltage dependent calcium channel

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; DILTIAZEM; FORSKOLIN; NIFEDIPINE; PROTEIN KINASE; VERAPAMIL;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; EMBRYONAL CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALIA;

EID: 1842375103     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031177.x     Document Type: Article

References (72)

1. Aigner T. G. (1995) Pharmacology of memory: cholinergic-glutamatergic interactions. Curr. Opin. Neurobiol. 5, 155-160.
2. Armstrong D. and Ekert R. (1987) Voltage activated calcium channels that must be phosphorylated to respond to membrane depolarisation. Proc. Natl. Acad. Sci. USA 84, 2518-2522.
3. Atack J. R., Perry E. K., Bonham J. R., Perry R. H., Tomlinson B. E., Blessed G., and Fairbairn A. (1983) Molecular forms of acetylcholinesterase in senile dementia of Alzheimer's type: selective loss of the intermediate (10S) form. Neurosci. Lett. 40, 199-204.
4. Bean B. P. (1989) Classes of calcium channels in vertebrate cells. Annu. Rev. Physiol. 51, 367-384.
5. Becker R. E. and Giacobini E. (1988) Mechanism of cholinesterase inhibition in senile dementia of the Alzheimer's type: clinical, pharmacological and therapeutic aspects. Drug Dev. Res. 12, 163-195.
6. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., and Soreq H. (1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5, 1063-1071.
7. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
8. Blokland A. (1995) Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Rev. 21, 285-300.
9. Brandon E. and Inestrosa N. C. (1993) Extracellular matrix components and amyloid in neuritic plaques of the Alzheimer's disease. Gen. Pharmacol. 24, 1063-1068.
10. 2+ influx induced by β-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol. 26, 325-338.
11. Bursztajn S., Schneider L. W., Jong Y.-J., and Berman S. A. (1991) Calcium and ionophore A23187 stimulates deposition of extracellular matrix and acetylcholinesterase release in cultured myotubes. Cell Tissue Res. 265, 95-103.
12. Cheun J. E. and Yeh H. H. (1991) Differentiation of a stem cell line toward a neuronal phenotype. Int. J. Dev. Neurosci. 9, 391-404.
13. Coleman B. A. and Taylor P. (1996) Regulation of acetylcholinesterase expression during neuronal differentiation. J. Biol. Chem. 271, 4410-4416.
14. Davidson R. M., Shajenko L., and Donta T. S. (1994) Amyloid β-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. Brain Res. 643, 324-327.
15. Davies P. and Maloney A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet ii, 1403.
16. Decker M. M. and Berman H. A. (1990) Dihydropyridine receptor regulation of acetylcholinesterase. J. Biol. Chem. 265, 11796-11803.
17. Ellman G. E., Courtney K. D., Andres V. Jr., and Featherstone R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
18. Evin G., Beyreuther K., and Masters C. L. (1994) Alzheimer's disease amyloid precursor protein ( AβPP): proteolytic processing, secretases and βA4 amyloid production. Amyloid: Int. J. Exp. Clin. Invest. 1, 263-280.
19. Fishman E. B., Siek G. C., MacCallum R. D., Bird E. D., Volicer L., and Marquis J. K. (1986) Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann. Neurol. 19, 246-252.
20. Ghiso J., Matsubara E., Koudinov A., Wisneiwski T., and Frangione B. (1993) The cerebrospinal fluid soluble form of Alzheimer's amyloid β is complexed to sp40, 40 (ApoJ), an inhibitor of the complement membrane attack complex. Biochem. J. 293, 27-30.
21. Hell J. W., Yokoyama C. T., Wong S. T., Warner C., Snutch T. P., and Catterall W. A. (1993) Differential phosphorylation of two size forms of the neuronal class C L-type calcium channel alpha 1 subunit. J. Biol. Chem. 268, 19451-19457.
22. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., and Beyreuther K. (1991) Human and rodent sequence analogs of Alzheimer's amyloid βA4 share similar properties and can be solubilized in buffers of pH 7.4. Eur. J. Biochem. 201, 61-69.
23. Houenou L. J., Sahuqué M. V., and Villageois A. P. (1993) Calcium influxes and calmodulin modulate the expression and physicochemical properties of acetylcholinesterase molecular forms during development in vivo. Cell. Mol. Neurobiol. 13, 217-232.
24. Inestrosa N. C., Alvarez A., Perez C. A., Moreno R. D., Vicente M., Linker C., Casanueva O. I., Soto C., and Garrido J. (1996) Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils - possible role of the peripheral site of the enzyme. Neuron 16, 881-891.
25. Jones-Villeneuve E. M. V., McBurney M. W., Rogers K. A., and Kalnins V. I. (1982) Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol. 94, 253-262.
26. Joseph R. and Han E. (1992) Amyloid β-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons. Biochem. Biophys. Res. Commun. 184, 1441-1447.
27. Kalaria R. N., Galloway P. G., and Perry G. (1991) Widespread amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17, 189-201.
28. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor and Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
29. Lando M., Abemayor E., Verity A., and Sidell N. (1990) Modulation of intracellular cyclic adenosine monophosphate levels and the differentiation response of human neuroblastoma cells. Cancer Res. 50, 722-727.
30. A receptors modulate early spontaneous excitatory activity in differentiating P19 neurons. J. Neurochem. 66, 233-242.
31. Luo Z., Fuentes M.-E., and Taylor P. (1994) Regulation of acetylcholinesterase mRNA stability by calcium during differentiation from myoblasts to myotubes. J. Biol. Chem. 269, 27216-27223.
32. Luo D. Z., Pincon-Raymond M., and Taylor P. (1996) Acetylcholinesterase and nicotinic acetylcholine receptor expression diverge in muscular dysgenic mice lacking the L-type calcium channel. J. Neurochem. 67, 111-118.
33. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
34. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
35. Mattson M. P. and Goodman Y. (1995) Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676, 219-224.
36. Mattson M. P. and Rydel R. E. (1996) Alzheimer's disease - amyloid ox-tox transducers. Nature 382, 674-675.
37. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) β-Amyloid peptides destabilise calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
38. Mattson M. P., Tomaselli K. J., and Rydel R. E. (1993) Calcium-destabilising and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
39. McBurney M. W., Reuhl K. R., Ally A. I., Nasipuri S., Bell J. C., and Craig J. (1988) Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J. Neurosci. 8, 1063-1073.
40. 2+ release in sarcoplasmic reticulum. J. Biol. Chem. 259, 2365-2374.
41. Meucci O., Grimaldi M., Scorziello A., Govoni S., Bergamaschi S., Yasumoto T., and Schettini G. (1992) Maitotoxin-induced intracellular calcium rise in PC12 cells: involvement of dihydropyridine-sensitive and ω-conotoxin-sensitive calcium channels and phosphoinositide breakdown. J. Neurochem. 59, 679-688.
42. Mirzabekov T., Lin M. C., Yuan W. L., Marshall P. J., Carman M., Tomaselli K., Lieberburg I., and Kagan B. L. (1994) Channel formation in planar lipid bilayers by a neurotoxic fragment of the β-amyloid peptide. Biochem. Biophys. Res. Commun. 202, 1142-1148.
43. Miyamoto H. and Racker E. J. (1982) Mechanism of calcium release from skeletal sarcoplasmic reticulum. Membr. Biol. 66, 193-201.
44. Morán M. A., Mufson E. J., and Gómez-Ramos P. (1993) Colocalization of cholinesterases with β amyloid protein in aged and Alzheimer's brains. Acta Neuropathol. 85, 362-369.
45. Nitsch R. M., Slack B. E., Wurtman R. J., and Growdon J. H. (1992) Release of Alzheimer amyloid precursor stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
46. Pederson W. A., Kloczewiak M. A., and Blusztajn J. K. (1996) Amyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA 93, 8068-8071.
47. Perez-Reyes E., Yuan W., Wei X., and Bers D. M. (1994) Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett. 342, 119-123.
48. Pessah I. N., Nieberg P. S., and Wilson B. W. (1993) Ryanodine induces maturation of embryonic acetylcholinesterase forms in cultured quail myotubules. Life Sci. 52, 1279-1285.
49. Prelli F., Castaño E., Glenner G. G., and Frangione B. (1988) Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51, 648-651.
50. Puymirat J., Etongue-Mayer P., and Dussault J. H. (1995) Thyroid hormones stabilise acetylcholinesterase mRNA in Neuro-2A cells that overexpress the β1 thyroid receptor. J. Biol. Chem. 270, 30651-30656.
51. Rotman E. I., Murphy B. J., and Catterall W. A. (1995) Sites of selective cAMP-dependent phosphorylation of the L-type calcium channel alpha 1 subunit from intact rabbit skeletal muscle myotubes. J. Biol. Chem. 270, 16371-16377.
52. 2+ mediate changes in acetylcholinesterase and acetylcholine receptors caused by muscle contraction. Proc. Natl. Acad. Sci. USA 82, 7121-7125.
53. Rudnicki M. A. and McBurney M. W. (1987) Cell culture methods and induction of differentiation of embryonal carcinoma cell lines, in Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (Robertson E. J., ed), pp. 19-50. IRL Press, Washington, D.C.
54. Sculptoreanu A., Rotman E., Takahashi M., Scheuer T., and Catterall W. A. (1993) Voltage-dependent potentiation of the activity of cardiac L-type calcium channel alpha 1 subunits due to phosphorylation by cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 90, 10135-10139.
55. Shearman M. S., Ragan C. I., and Iversen L. L. (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA 91, 1470-1474.
56. Small D. H., Michaelson S., and Sberna G. (1996) Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28, 453-483.
57. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D.C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
58. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassel J., and Wight T. N. (1988) The presence of heparan sulfate proteoglycan in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
59. Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., and Kling A. (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315, 1241-1245.
60. 2+ influx in PC12h cells in culture. Neurosci. Lett. 173, 147-150.
61. Thomas A. P. and Delaville F. (1991) The use of fluorescent indicators for measurements of cytosolic-free calcium concentration in cell populations and single cells, in Cellular Calcium. A Practical Approach (McCormack J. G. and Cobbold P. H., eds), pp. 1-54. IRL Press, Oxford, U.K.
62. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68, 265-271.
63. Ulrich J., Meier-Ruge W., Probst A., Meier E., and Ipsen S. (1990) Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol. 80, 624-628.
64. Wasserman L. M., Newsham I., Huang H. J. S., and Cavenee W. K. (1996) cAMP effects on myogenic gene expression in rhabdomyosarcoma cells. Exp. Cell Res. 227, 55-62.
65. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62, 372-375.
66. Whitson J. S. and Appel S. H. (1995) Neurotoxicity of Aβ amyloid protein in vitro is not altered by calcium channel blockade. Neurobiol. Aging 16, 5-10.
67. Winkler J., Suhr S. T., Gage F. H., Thal L. J., and Fisher L. J. (1995) Essential role of neocortical acetylcholine in spatial memory. Nature 375, 484-487.
68. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
69. Woscholski R. and Marme D. (1992) An endogenous membranebound protein inhibits the phosphorylation of the L-type calcium channel by the cAMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 186, 1588-1593.
70. Yan S. D., Chen X., Fu J., Chen M., Zhu H. J., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
71. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
72. Zhou Y., Gopalakrishnan V., and Richardson J. S. (1996) Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67, 1419-1425.